At a cancer treatment center in Iran's capital of Tehran, a doctor's fight to treat her cancer patients has become harder. As U.S. sanctions sink in, the flow of medicine and medical supplies in Iran appears to have slowed — and the reasons are difficult to pin down.
Dr. Mastaneh Sanei, an oncologist at the Roshana Cancer Center, says she's treating patients without the benefits of consistently functioning equipment and a reliable supply of drugs.
With the right treatment, she says, "you may not cure these patients, but they have the chance to prolong survival."
The shortages affecting Iran's hospitals and clinics are a particularly perilous example of an economic crisis that has worsened since the Trump administration reimposed economic sanctions on the country. The 2015 nuclear deal offered Iran economic relief in exchange for limiting its nuclear program, but the U.S. withdrew from the agreement last year and penalize doing business with Iran's oil, banking and other sectors and individuals.
Listen to the full conversation on NPR.
More from CNAS
ReportsSanctions by the Numbers
This edition of Sanctions by the Numbers explores Iran sanctions, tracking how designations and delistings have evolved over time, the dozens of countries affected by Iran-rel...
By Abigail Eineman
CommentarySharper: The Future of U.S. Sanctions Policy
Sanctions are increasingly common in U.S. foreign policy and economic statecraft. But they are not a cure-all....
By Kaleigh Thomas, Cole Stevens & Chris Estep
CommentaryDirty Money Is an Ongoing Threat on Both Sides of the Atlantic
Two developments last week, in the United Kingdom and the United States, highlighted how their common adversaries are still exploiting the global financial system, using long-...
By Neil Bhatiya
PodcastThe Trump Administration’s Latest Moves to Dismantle the Iran Nuclear Agreement with Peter Harrell and Richard Nephew
On May 27, the Trump administration announced that it was withdrawing sanctions waivers that had allowed Russian, Chinese and European companies to work with Iran on sensitive...
By Peter Harrell